SCHEMBL8808583

SCHEMBL8808583

COc1ccc2nc(-c3ccccc3)cc(C(=O)Nc3ccc(CCCCNC(C)c4ccc(OC)c(OC)c4)cc3)c2c1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 6/20 0.55
▸ CA1 P00915 6/20 0.55
▸ CA2 P00918 6/20 0.55
▸ CA9 Q16790 6/20 0.55
▸ CYP3A4 P08684 3/20 0.53
▸ MAPT P10636 4/20 0.53
▸ TP53 P04637 2/20 0.53
▸ TACR3 P29371 2/20 0.52
▸ KDM4E B2RXH2 2/20 0.49
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ PLA2G2A P14555 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808191 0.90 MAPT (0.62) CA12CA1CA2CA9CYP3A4
SCHEMBL8809325 0.89 MEN1 (0.58) CA12CA1CA2CA9CYP3A4
SCHEMBL8830724 0.87 MAPT (0.66) CA12CA1CA2CA9CYP3A4
SCHEMBL8808579 0.83 CA12 (0.57) CA12CA1CA2CA9CYP3A4
SCHEMBL8808572 0.82 CA12 (0.56) CA12CA1CA2CA9CYP3A4
SCHEMBL8807114 0.81 MEN1 (0.59) CA12CA1CA2CA9CYP3A4
SCHEMBL8806643 0.77 ABCG2 (0.55) MAPTKDM4EMEN1KMT2ANPC1
SCHEMBL8807874 0.76 ABCG2 (0.43) MAPTKDM4EMEN1KMT2ANPC1
SCHEMBL28844500 0.76 TACR3 (0.76) CA12CA1CA2CA9CYP3A4
SCHEMBL8807581 0.76 CYP3A4 (0.63) CA12CA1CA2CA9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback